EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence and Duration of Potential Drug–Drug Interactions Among US Nursing Home Residents, 2018–2020

Prävalenz und Dauer potenzieller Arzneimittel-Arzneimittel-Interaktionen bei US-Pflegeheimbewohner:innen, 2018–2020

Laura A Reich iD, Lori A Daiello, Sarah D Berry, Adam M D'Amico, Douglas P Kiel, Daniel A Harris, Kaleen N Hayes iD, Charles E Leonard, Yu-Chia Sam Hsu, Andrew R Zullo iD

Journal of the American Geriatrics Society · 2025-12 · 73 (12) · 3766-3777

DOI: 10.1111/jgs.70175 ↗

Auf einen Blick

In einer Kohortenstudie hatten 61,6 % der US-Pflegeheimbewohner:innen mindestens eine potenzielle DDI. Die häufigste Interaktion war die gleichzeitige Einnahme von ≥ 3 ZNS-wirksamen Arzneien.

Fragestellung

Wie häufig und wie lange waren US-Pflegeheimbewohner:innen von potenziellen, klinisch relevanten DDIs betroffen?

Methode

Kohortenstudie mit Daten aus Medicare Claims und Minimum Data Set 3.0; Auswertung von 98 potenziellen DDIs bei Medicare-Fee-for-Service-Begünstigten ab 66 Jahren in Pflegeheimen mit Part-D-Daten, 2018–2020.

Ergebnisse

Unter 485.251 Pflegeheimbewohner:innen traten bei 61,6 % ≥ 1 potenzielle DDI auf. Die häufigste DDI war ≥ 3 ZNS-aktive Medikamente bei 27,1 % (95 %-KI 27,0–27,2). Die längste mediane Exposition hatte die Kombination aus Acetylcholinesterasehemmern und herzfrequenzsenkenden Arzneien: 81 Tage (Q1–Q3 24–235).

Schlussfolgerung der Autor:innen

Nahezu zwei Drittel der Pflegeheimbewohner:innen waren Kombinationen mit potenziellen DDIs ausgesetzt; Prävalenz und Expositionsdauer variierten je nach einzelner DDI.

Kernaussagen

  • 61,6 % hatten mindestens eine potenzielle DDI.
  • Häufigste DDI: ≥ 3 ZNS-aktive Medikamente bei 27,1 %.
  • Längste mediane Exposition: 81 Tage bei AChE-Hemmern plus herzfrequenzsenkenden Arzneien.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 17.10.2025. Verfasst von Laura A Reich und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gerontology and Healthcare Research, Department of Health Services, Policy, and Practice, Brown University School of Public Health, Provid…. Hauptthemen laut MEDLINE: Nursing Homes, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nursing home (NH) residents are at increased risk of drug–drug interactions (DDIs) due to multimorbidity and polypharmacy. While prior research suggests that many DDIs lead to adverse drug events in older adults, the extent of exposure to potentially clinically relevant DDIs among United States (US) NH residents is largely unknown.

Methods

In this cohort study, we calculated the prevalence and duration of exposure to 98 potential DDIs among US NH residents from 2018 to 2020. DDIs were sourced from three expert consensus publications, some of which defined similar interactions and overlapping drug combinations, allowing comparisons within and across lists. Data were drawn from Medicare claims linked to Minimum Data Set 3.0 clinical assessments. Eligible residents included Medicare Fee‐for‐Service beneficiaries aged ≥ 66 years living in NHs with observable Part D prescription drug data. DDI exposure was defined as ≥ 1 day of concurrent use of orally administered medications. Prevalence was calculated as the proportion of residents exposed to each DDI; duration was measured as the median number of days residents concurrently used the medications of interest.

Results

Among 485,251 NH residents, 61.6% experienced ≥ 1 potential DDI over 272,780 person‐years. The 12 most prevalent DDIs involved central nervous system (CNS)‐active drugs, anticholinergics, antihypertensives, opioids, and diuretics. Of these DDIs, concurrent use of acetylcholinesterase inhibitors and heart rate‐reducing drugs had the longest median exposure duration (81 days; Q1–Q3, 24–235). The most prevalent DDI, concomitant use of ≥ 3 CNS‐active drugs, was observed in 27.1% (95% CLs, 27.0%, 27.2%) of residents.

Conclusions

Nearly two‐thirds of NH residents were exposed to medication combinations linked to potential DDIs, although the prevalence and duration of exposure associated with individual DDIs varied. Future research should determine which DDIs are most clinically significant and investigate barriers to reducing exposure duration in this high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nursing HomesDrug-Related Side Effects and Adverse ReactionsHumansDrug InteractionsAgedUnited StatesMaleFemalePrevalenceAged, 80 and overPolypharmacyCohort StudiesTime Factors

Stichwörter der Autor:innen

drug–drug interactionsnursing homeolder adultspolypharmacy

Autor:innen und Institutionen

  • Center for Gerontology and Healthcare Research, Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
  • Department of Health Services, Policy, and Practice, Brown University School of Public Health, Brown University, Providence, Rhode Island, USA.
  • Department of Neurology, Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Hinda and Arthur Marcus Institute for Aging Research and Department of Medicine, Hebrew SeniorLife, Boston, Massachusetts, USA.
  • Department of Epidemiology, College of Health Sciences, University of Delaware, Newark, Delaware, USA.
  • Department of Epidemiology, Brown University School of Public Health, Brown University, Providence, Rhode Island, USA.

ORCID-Profile: Laura A Reich, Kaleen N Hayes, Andrew R Zullo

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Reich, L. A., Daiello, L. A., Berry, S. D., D'Amico, A. M., Kiel, D. P., Harris, D. A., Hayes, K. N., Leonard, C. E., Hsu, Y. S., & Zullo, A. R. (2025). Prevalence and Duration of Potential Drug–Drug Interactions Among US Nursing Home Residents, 2018–2020. Journal of the American Geriatrics Society, 73(12), 3766-3777. https://doi.org/10.1111/jgs.70175

Vancouver

Reich LA, Daiello LA, Berry SD, D'Amico AM, Kiel DP, Harris DA, et al. Prevalence and Duration of Potential Drug–Drug Interactions Among US Nursing Home Residents, 2018–2020. Journal of the American Geriatrics Society. 2025;73(12):3766-3777. doi:10.1111/jgs.70175

BibTeX
@article{Reich2025,
  author = {Reich, Laura A and Daiello, Lori A and Berry, Sarah D and D'Amico, Adam M and Kiel, Douglas P and Harris, Daniel A and Hayes, Kaleen N and Leonard, Charles E and Hsu, Yu-Chia Sam and Zullo, Andrew R},
  title = {Prevalence and Duration of Potential Drug–Drug Interactions Among US Nursing Home Residents, 2018–2020},
  journal = {Journal of the American Geriatrics Society},
  year = {2025},
  volume = {73},
  number = {12},
  pages = {3766--3777},
  doi = {10.1111/jgs.70175}
}
Kostenlos starten →